Unilife, a medical device and technology company, has announced the signing of an agreement with a global pharmaceutical company seeking to use the Unilife Ocu-ject ocular drug delivery system to deliver a target injectable therapy into the ...
Tags: Unilife, medical device
Siemens Healthcare Diagnostics and Pfizer have entered into a master collaboration agreement to design, develop and commercialize diagnostic tests for therapeutic products across Pfizer’s pipeline. Pursuant to the terms of the ...
Tags: Siemens, Pfizer, Companion Diagnostics
Stelis Biopharma and Pieris, a next generation therapeutic protein R&D firm, have started a long-term collaboration for clinical development and commercialization of multiple novel Anticalin-based protein therapeutics worldwide, primarily ...
iCo Therapeutics has announced that on 26 November 2013, US patent 8,592,382 was issued for the Oral Amphotericin B platform (Oral AmpB) providing protection around oral delivery of the drug. With the recent receipt of ethics approval, ...
Tags: iCo Therapeutics, Medicine
U.S. and European researchers say they may be able to explain the biological mechanism resulting in the therapeutic effects of meditation. Study author Richard J. Davidson, founder of the Center for Investigating Healthy Minds at the ...
BIND Therapeutics, a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, has amended its development and commercialization collaboration agreement with Amgen to extend the period ...
U.S. allergists say a new long-term medication in under-the-tongue tablet form is promising and may even have the potential to cure hay fever. Officials at the American Academy of Allergy, Asthma & Immunology said allergy immunotherapy is ...
BioWa, a wholly owned subsidiary of Kyowa Hakko Kirin, and Lonza, a biotechnology company, have entered into a licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca. MedImmune has licensed ...
Sutro Biopharma has received $26m in a Series D financing, which will be used for the expansion of its proprietary immuno-oncology product pipeline. The company is currently using its cell-free protein synthesis technology to develop new ...
Roche and Prothena have agreed to jointly develop and commercialize new antibodies that target alpha-synuclein, including PRX002, Prothena's monoclonal antibody for the treatment of Parkinson's disease (PD). Currently, PRX002 is in ...
Receptos, a biopharmaceutical company, has announced that Ono Pharmaceuticals has elected to amend and expand the existing collaboration agreement between the parties to include transfer to Ono of the Receptos G-protein-coupled receptor ...
Tags: Pharmaceuticals, Receptos
The U.S. Food and Drug Administration has released the final version of a voluntary plan to phase out the use of certain antibiotics in food animals. Antibiotics are added to the feed or drinking water of cattle, hogs, poultry and other ...
Tags: Agriculture, Food
Baxter International has filed an application to the US Food and Drug Administration (FDA) for a pediatric indication for Rixubis [Coagulation Factor IX (Recombinant)] to treat hemophilia B. The submission was based on a Phase II/III ...
Proteostasis Therapeutics and Biogen Idec have collaborated to research and develop new therapies based on the inhibition of Usp14, a deubiquitinating enzyme, for the treatment of certain neurodegenerative disorders. Under the deal, ...
Efforts to apply psychological science to aggressive drivers are in their infancy but may have great potential, researchers in Canada said. Christine Wickens of the Centre for Addiction and Mental Health in Toronto and colleagues at York ...